Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3958743)

Published in J Leukoc Biol on December 12, 2013

Authors

Johanna K Morales1, Sheinei J Saleem, Rebecca K Martin, Bryan L Saunders, Brian O Barnstein, Travis W Faber, Nicholas A Pullen, Elizabeth Motunrayo Kolawole, Keith B Brooks, Sarah K Norton, Jamie Sturgill, Laura Graham, Harry D Bear, Joseph F Urban, Chris S Lantz, Daniel H Conrad, John J Ryan

Author Affiliations

1: 1.Biology Department, Richmond, VA 23284-2012, USA. jjryan@vcu.edu.

Articles cited by this

Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol (2009) 9.41

Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol (2008) 9.25

IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity (1998) 4.65

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol (2007) 4.65

IgE and mast cells in allergic disease. Nat Med (2012) 3.14

Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol (2010) 3.12

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother (2010) 3.00

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood (2007) 2.65

Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med (2000) 2.46

The tyrosine kinase network regulating mast cell activation. Immunol Rev (2009) 2.29

Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int Immunopharmacol (2009) 2.14

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology (2013) 2.14

Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J Immunol (2000) 1.52

Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunol Invest (2012) 1.43

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS One (2010) 1.39

T cells in helminth infection: the regulators and the regulated. Trends Immunol (2012) 1.39

Myeloid-derived suppressor cells in parasitic infections. Eur J Immunol (2010) 1.36

Delayed expulsion of adult Trichinella spiralis by mast cell-deficient W/Wv mice. Infect Immun (1983) 1.33

TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol (2010) 1.27

Targeting immune suppressing myeloid-derived suppressor cells in oncology. Crit Rev Oncol Hematol (2010) 1.25

TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol (1994) 1.18

Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J Immunol (2012) 1.15

Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? World J Gastroenterol (2012) 1.12

Rejection of the intestinal parasite Nippostrongylus brasiliensis by mast cell-deficient W/Wv anemic mice. Infect Immun (1981) 1.10

Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J Immunol (2011) 1.05

Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas. Curr Opin Oncol (2010) 1.04

Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness. Mucosal Immunol (2011) 1.04

ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch. J Immunol (2011) 0.99

Myeloid derived suppressor cells: Targets for therapy. Oncoimmunology (2013) 0.94

Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis. Immunol Lett (2013) 0.90

LPS-induced CD11b+Gr1(int)F4/80+ regulatory myeloid cells suppress allergen-induced airway inflammation. Int Immunopharmacol (2011) 0.88

Anaphylaxis: mechanisms of mast cell activation. Chem Immunol Allergy (2010) 0.88

129/SvJ mice have mutated CD23 and hyper IgE. Cell Immunol (2008) 0.85

Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells. J Immunol (2013) 0.85

Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses. Immunol Invest (2012) 0.84

TNF-alpha antagonism in severe asthma? Recent Pat Inflamm Allergy Drug Discov (2010) 0.81

Articles by these authors

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol (2008) 6.31

Protective immune mechanisms in helminth infection. Nat Rev Immunol (2007) 5.66

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology (2005) 5.26

IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature (2010) 5.07

Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med (2004) 4.45

Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol (2004) 4.41

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol (2012) 4.33

Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med (2006) 4.16

Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev (2004) 3.63

Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol (2003) 3.40

The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest (2006) 3.33

Gender bias in autoimmunity is influenced by microbiota. Immunity (2013) 2.88

An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med (2012) 2.60

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. Lancet Oncol (2013) 2.59

Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol (2007) 2.50

Alternatively activated macrophages in helminth infections. Curr Opin Immunol (2007) 2.41

The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma. Immunity (2010) 2.38

Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2002) 2.28

Dependence of IL-4, IL-13, and nematode-induced alterations in murine small intestinal smooth muscle contractility on Stat6 and enteric nerves. J Immunol (2003) 2.27

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol (2005) 2.17

Unique maturation program of the IgE response in vivo. Immunity (2007) 2.15

The immune response to parasitic helminths: insights from murine models. Trends Immunol (2003) 2.14

Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int Immunopharmacol (2009) 2.14

Dioxins: an overview. Environ Res (2006) 2.11

Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology (2008) 2.09

Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog (2009) 2.07

A signature of immune function genes associated with recurrence-free survival in breast cancer patients. Breast Cancer Res Treat (2011) 1.99

Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med (2009) 1.97

Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol (2004) 1.92

Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med (2004) 1.91

ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat Immunol (2006) 1.83

Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension. Circ Res (2012) 1.81

IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice. J Clin Invest (2011) 1.77

GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension. Circulation (2012) 1.71

Role of dynamin-related protein 1 (Drp1)-mediated mitochondrial fission in oxygen sensing and constriction of the ductus arteriosus. Circ Res (2013) 1.67

Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol (2002) 1.66

GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res Treat (2009) 1.60

IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J Immunol (2002) 1.58

Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice. Vaccine (2010) 1.54

Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function. Blood (2009) 1.54

Stat5 expression is critical for mast cell development and survival. Blood (2003) 1.48

ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. J Exp Med (2010) 1.47

Enteric nematodes induce stereotypic STAT6-dependent alterations in intestinal epithelial cell function. J Immunol (2004) 1.46

Amphiregulin, a TH2 cytokine enhancing resistance to nematodes. Science (2006) 1.44

Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.42

Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol (2008) 1.42

Fullerene nanomaterials inhibit the allergic response. J Immunol (2007) 1.40

Critical role of IL-25 in nematode infection-induced alterations in intestinal function. J Immunol (2010) 1.40

Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer. J Surg Oncol (2003) 1.39

Peripheral CD4 T cells rapidly accumulate at the host: parasite interface during an inflammatory Th2 memory response. J Immunol (2004) 1.38

Dynamics of lung macrophage activation in response to helminth infection. J Leukoc Biol (2008) 1.38

Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Cancer Res (2008) 1.38

Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum. Infect Immun (2005) 1.38

Alterations in the porcine colon microbiota induced by the gastrointestinal nematode Trichuris suis. Infect Immun (2012) 1.37

Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J Immunol (2008) 1.35

Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal distal intestine. Infect Immun (2007) 1.35

IL-4 exacerbates anaphylaxis. J Immunol (2003) 1.34

Mechanisms of neonatal mucosal antibody protection. J Immunol (2006) 1.32

Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer Immunol Immunother (2008) 1.30

T cell-derived IL-3 plays key role in parasite infection-induced basophil production but is dispensable for in vivo basophil survival. Int Immunol (2008) 1.30

IL-2 and autocrine IL-4 drive the in vivo development of antigen-specific Th2 T cells elicited by nematode parasites. J Immunol (2005) 1.29

Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. FASEB J (2013) 1.28

HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis. BMC Public Health (2010) 1.28

Immune regulation of protease-activated receptor-1 expression in murine small intestine during Nippostrongylus brasiliensis infection. J Immunol (2005) 1.27

Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. J Immunol (2006) 1.26

Cutting edge: genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses. J Immunol (2007) 1.26

Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Transl Med (2009) 1.26

The distinctive germinal center phase of IgE+ B lymphocytes limits their contribution to the classical memory response. J Exp Med (2013) 1.26

The role of B cells in the development of CD4 effector T cells during a polarized Th2 immune response. J Immunol (2007) 1.25

Requirements for the development of IL-4-producing T cells during intestinal nematode infections: what it takes to make a Th2 cell in vivo. Immunol Rev (2004) 1.24

Impaired FcepsilonRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J Immunol (2005) 1.24

Worm burden-dependent disruption of the porcine colon microbiota by Trichuris suis infection. PLoS One (2012) 1.23

Catecholamines in a macrophage cell line. J Neuroimmunol (2003) 1.21

Kidney transplantation and gender disparity. Am J Nephrol (2005) 1.20

Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J Exp Med (2010) 1.19

Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension. Pulm Circ (2013) 1.19

Autologous dendritic cell vaccines for non-small-cell lung cancer. J Clin Oncol (2004) 1.18

A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. Am J Physiol Lung Cell Mol Physiol (2012) 1.18

Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity (2009) 1.17

The role of OX40 ligand interactions in the development of the Th2 response to the gastrointestinal nematode parasite Heligmosomoides polygyrus. J Immunol (2003) 1.17

STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease. Blood (2009) 1.17

Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. Surgery (2013) 1.16

Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J Immunol (2012) 1.15

A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. J Allergy Clin Immunol (2012) 1.15

Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGFbeta after lipopolysaccharide stimulation. J Immunol (2006) 1.15

Contribution of 5-HT2A receptor in nematode infection-induced murine intestinal smooth muscle hypercontractility. Gastroenterology (2006) 1.14

IL-13 receptor alpha2 regulates the immune and functional response to Nippostrongylus brasiliensis infection. J Immunol (2009) 1.13

Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation. Eur J Immunol (2009) 1.12

Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells. J Biol Chem (2007) 1.12